Ipamorelin 10mg
The Cleanest GH Secretagogue for Selective Growth Hormone Release
Ipamorelin is a selective GH secretagogue that stimulates pituitary GH release via the ghrelin receptor (GHS-R1a) without significantly raising cortisol or prolactin — making it the preferred selective GHRP for GH research protocols.
The Cleanest GH Secretagogue for Selective Growth Hormone Release
Ipamorelin (pentapeptide) is the first highly selective ghrelin receptor agonist developed specifically to stimulate GH without the unwanted cortisol and prolactin surges seen with GHRP-2 and GHRP-6. Its GH pulse is physiologically similar to natural pulsatile release.
As one of the most studied compounds in the growth & body comp research space, Ipamorelin has attracted sustained scientific interest across GH secretagogue research, Growth hormone axis studies, Anti-aging protocols. Peer-reviewed evidence indicates that minimal cortisol and prolactin stimulation vs. GHRP-2, which has positioned Ipamorelin as a reference standard for researchers exploring gh secretagogue research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Ipamorelin Documented Benefits: 4 Documented Mechanisms
Selective GH Release
Stimulates GH release without significant cortisol or prolactin elevation, the cleanest GHRP profile.
Physiological GH Pulse
Mimics natural pulsatile GH secretion patterns, preserving normal hypothalamic-pituitary feedback.
Muscle and Fat Effects
Downstream IGF-1 increase supports lean mass maintenance and fat mobilization.
Synergy with GHRH
Combines powerfully with CJC-1295 for amplified GH release via complementary mechanisms.
How Ipamorelin Works: Molecular Mechanism & Pathway
Pentapeptide GHS-R1a (ghrelin receptor) agonist stimulating pituitary somatotroph GH secretion while maintaining normal GHIH/somatostatin feedback regulation.
The 4 primary research pathways identified for Ipamorelin — Selective GH Release, Physiological GH Pulse, Muscle and Fat Effects — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that physiological pulsatile GH release pattern, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Ipamorelin's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Ipamorelin is routinely studied alongside CJC-1295 and Sermorelin in growth & body comp-focused compound panels. Researchers investigating gh secretagogue research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that strong synergy with CJC-1295 in combination studies has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Ipamorelin research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Minimal cortisol and prolactin stimulation vs. GHRP-2
- Physiological pulsatile GH release pattern
- Strong synergy with CJC-1295 in combination studies
Ideal For
- GH secretagogue research
- Growth hormone axis studies
- Anti-aging protocols
- Body composition research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Ipamorelin. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Minimal cortisol and prolactin stimulation vs. GHRP-2
Physiological pulsatile GH release pattern
Strong synergy with CJC-1295 in combination studies
Third-Party Verified Every Batch
Each vial of Ipamorelin is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
